Gastroenterology -Therapeutics & Hepatology

Esophageal Disorders: Current Treatments

Esophageal disorders, including gastroesophageal reflux disease (GERD), esophageal cancer, and dysphagia, present complex treatment challenges that have seen significant advancements in recent years. Current treatments for GERD include improved proton pump inhibitors (PPIs) and newer medications such as potassium-competitive acid blockers, offering enhanced symptom relief and mucosal healing. For severe cases unresponsive to medication, minimally invasive procedures like laparoscopic fundoplication and endoscopic radiofrequency ablation provide effective alternatives. Esophageal cancer management has progressed with advancements in targeted therapies and immunotherapy. Drugs like pembrolizumab and nivolumab are now used to enhance immune responses against cancer cells, while precision medicine approaches guide tailored treatment plans based on genetic profiling. For dysphagia, innovative interventions such as balloon dilation and endoscopic stenting are improving patient outcomes. Additionally, advancements in diagnostic tools, including high-resolution manometry and pH monitoring, are aiding in precise diagnosis and personalized treatment strategies. These current treatments are significantly enhancing the management of esophageal disorders, improving patient quality of life.